| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | |
Result : Searchterm 'Endorem' found in 1 term [] and 4 definitions []
| 1 - 5 (of 5) Result Pages : [1] | | | | | | |
| |
|
A brand name for ferumoxide (same as Feridex®)
Endoremâ„¢ is a black to reddish-brown aqueous colloid of superparamagnetic iron oxide associated with dextran for intravenous administration as a MRI contrast medium for the detection of liver lesions that are associated with an alteration in the RES.
Endoremâ„¢ is taken up by macrophages, found only in healthy liver cells but not in most tumors. Tissues such as metastases, primary liver cancer, cysts and various benign tumors, adenomas and hyperplasia retain their native signal intensity, so the contrast between normal and abnormal tissue is increased.
See also Ferumoxide.
Drug Information and Specification
T2, predominantly negative enhancement
r1=40.0, r2=160, B0=0.47T
PHARMACOKINETIC
RES-directed
CONCENTRATION
11.2mg Fe/ml
PREPARATION
Suspend in an isotonic glucose solution
DEVELOPMENT STAGE
For sale
PRESENTATION
Ampoule of 8 mL
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT STAGE
DISTRIBUTOR
EU Brazil
Endorem™
for sale
| | | | | • Share the entry 'Endorem™': | | | | Further Reading: | News & More:
|
|
| |
| | | | | |
| |
|
A brand name for ferumoxide (same as Endorem™)
Feridex® is a sterile aqueous colloid of superparamagnetic iron oxide associated with dextran for intravenous administration as a MRI contrast medium for the detection of liver lesions that are associated with an alteration in the RES.
Feridex® is taken up by macrophages, found only in healthy liver cells but not in most tumors. Tissues such as metastases, primary liver cancer, cysts and various benign tumors, adenomas and hyperplasia retain their native signal intensity, so the contrast between normal and abnormal tissue is increased.
Feridex® is a black to reddish-brown aqueous colloid.
See also Ferumoxide. In November 2008, AMAG Pharmaceuticals, Inc. decided to discontinue the manufacturing of Feridex.
Drug Information and Specification
T2, predominantly negative enhancement
r1=40.0, r2=160, B0=0.47T
PHARMACOKINETIC
RES-directed
CONCENTRATION
11.2mg Fe/ml
PREPARATION
Suspend in an isotonic glucose solution
DEVELOPMENT STAGE
For sale
PRESENTATION
Ampoule of 8 mL
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT STAGE
DISTRIBUTOR
| | | | • View the DATABASE results for 'Feridex®' (9).
| | | | Further Reading: | | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
MRI Contrast Agents:
Contact Information
MAIL
Guerbet
Boite postale 50400
95943 Roissy
Charles de Gaulle Cedex
FRANCE
| | | | • View the DATABASE results for 'Guerbet S.A.' (7).
| | | • View the NEWS results for 'Guerbet S.A.' (2).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
The characteristics of a hepatobiliary contrast agent are specific liver uptake and excretion via the biliary system. The paramagnetic substance (e.g. manganese, gadolinium) is taken up by normal hepatocytes. Diseased liver tissue did not include hepatocytes or their function is disturbed. Therefore, the signal of healthy liver tissue increases on T1 weighted sequences, but not in the liver lesions.
Another type of liver imaging contrast agent is superparamagnetic iron oxide. These particles accumulate in the reticuloendothelial system (RES) of the liver, and darken the healthy liver tissue in T2 weighted images. RES cells (including Kupffer cells) are existing in healthy liver tissue, in altered tissue with reduced RES activity or without RES cells the contrast agent concentration is also low or not existing, which improves the liver to lesion contrast.
Benefits of hepatobiliary contrast agents:
•
Liver lesions (e.g., tumor, metastases, haemangioma etc.) are better detectable and to characterize.
•
These contrast agents are useful to analyze and evaluate the liver function (in cases of diffuse liver diseases e.g., cirrhosis).
•
Imaging of the gallbladder and biliary system is improved.
Differences of a hepatobiliary contrast agent compared with a targeted contrast agent for Kupffer cells:
•
The higher number of hepatocytes than Kupffer cells improves the uptake effectiveness of the contrast agent.
•
Hepatobiliary contrast agents enable a better opacification of the biliary ducts and the gallbladder caused by the biliary excretion.
•
Hepatobiliary contrast media are fast excreted agents. RES targeted contrast agents remain longer in the body, a fact that can increase possible side effects.
See also Superparamagnetic Contrast Agents, Hepatobiliary Chelates, Liver Imaging, Endoremâ„¢, Primovistâ„¢, and Classifications, Characteristics, etc.
See also the related poll result: ' The development of contrast agents in MRI is' | | | | • View the DATABASE results for 'Hepatobiliary Contrast Agents' (11).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
( SPIO) Relatively new types of MRI contrast agents are superparamagnetic iron oxide-based colloids (median diameter greater than 50nm). These compounds consist of nonstoichiometric microcrystalline magnetite cores, which are coated with dextrans (in ferumoxide) or siloxanes (in ferumoxsil). After injection they accumulate in the reticuloendothelial system (RES) of the liver (Kupffer cells) and the spleen. At low doses circulating iron decreases the T1 time of blood, at higher doses predominates the T2* effect.
SPIO agents are much more effective in MR relaxation than paramagnetic agents. Since hepatic tumors either do not contain RES
cells or their activity is reduced, the contrast between liver and lesion is improved. Superparamagnetic iron oxides cause noticeable shorter T2 relaxation times with signal loss in the targeted tissue (e.g., liver and spleen) with all standard pulse sequences.
Magnetite, a mixture of FeO and Fe2O3, is one of the used iron oxides. FeO can be replaced by Fe3O4.
Use of these colloids as tissue specific contrast agents is now a well-established area of pharmaceutical development. Feridex®, Endorem™, GastroMARK®, Lumirem®, Sinerem®, Resovist® and more patents pending tell us that the last word in this area is not said.
Some remarkable points using SPIO:
•
A minimum delay of about 10 min. between injection (or infusion) and MR imaging, extends the examination time.
•
Cross-section flow void in narrow blood vessels may impede the differentiation from small liver lesions.
•
Aortic pulsation artifacts become more pronounced.
See also Superparamagnetism, Superparamagnetic Contrast Agents and Classifications, Characteristics, etc.. | | | | • View the DATABASE results for 'Superparamagnetic Iron Oxide' (32).
| | | • View the NEWS results for 'Superparamagnetic Iron Oxide' (3).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | |
| | 1 - 5 (of 5) Result Pages : [1] |
| |
|
| |
| Look Ups |
| |